Entest BioMedical Inc. announced that Dr. Christine Ichim has joined the company as its Director of Research. Dr. Ichim was previously with the Salk Institute where she conducted research in the areas of cancer and stem cell division, cell senescence and aging.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2020 | Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019 | CI |
2019 | Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.92K | |
+191.37% | 6.97B | |
+5.09% | 1.04B | |
+2.10% | 982M | |
+41.91% | 872M | |
+24.45% | 814M | |
+11.31% | 675M | |
+1.72% | 664M | |
-.--% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- ETNI Stock
- News Entest Group, Inc.
- Christine Ichim Joins Entest BioMedical Inc. as Director of Research